Cited by 913Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchNeural and Behavioral Psychology Studies

The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse?

Pierce, R. Christopher, Kumaresan, Vidhya·2006·Neuroscience & Biobehavioral Reviews

Abstract

In this review we will critically assess the hypothesis that the reinforcing effect of virtually all drugs of abuse is primarily dependent on activation of the mesolimbic dopamine system. The focus is on five classes of abused drugs: psychostimulants, opiates, ethanol, cannabinoids and nicotine. For each of these drug classes, the pharmacological and physiological mechanisms underlying the direct or indirect influence on mesolimbic dopamine transmission will be reviewed. Next, we evaluate behavioral pharmacological experiments that specifically assess the influence of activation of the mesolimbic dopamine system on drug reinforcement, with particular emphasis on animal experiments using drug self-administration paradigms. There is overwhelming evidence that all five classes of abused drugs increase dopamine transmission in limbic regions of the brain through interactions with a variety of transporters, ionotropic receptors and metabotropic receptors. Behavioral pharmacological experiments indicate that increased dopamine transmission is clearly both necessary and sufficient to promote psychostimulant reinforcement. For the other four classes of abused substances, self-administration experiments suggest that although increasing mesolimbic dopamine transmission plays an important role in the reinforcing effects of opiates, ethanol, cannabinoids and nicotine, there are also dopamine-independent processes that contribute significantly to the reinforcing effects of these compounds…

Integrity signals

Registry

Crossref · 10.1016/j.neubiorev.2005.04.016

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The mesolimbic dopaminergic pathway is associated with addictive behaviors, including drug use and binge eating disorders.

    “The mesolimbic dopaminergic pathway has been associated with addictive behaviors, including drug use and binge eating disorders [7, 8].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pierce, R. C., & Kumaresan, V.
Affiliations
Boston University (US)
Corresponding author
Pierce, R. Christopher
Venue
Neuroscience & Biobehavioral Reviews
Publisher
Elsevier BV
Published
2006-01
Volume
30
Issue
2
Pages
215-238
ISSN
0149-7634 (ISSN-L)
OpenAlex
W1998674360
Cited by
913
References
24
Citations by year
2026: 22 · 2025: 24 · 2024: 14 · 2023: 24 · 2022: 44 · 2021: 30 · 2020: 100 · 2019: 38 · 2018: 41 · 2017: 37 · 2016: 65 · 2015: 64 · 2014: 58 · 2013: 54 · 2012: 53
FWCI
2.39
Type
journal article
Language
en
Open access
closed
Locations
  • Neuroscience & Biobehavioral Reviews (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Brown University
  • National Institute on Drug Abuse (R01DA015214)
  • National Center for Research Resources (P20 RR1578)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
mesolimbic dopamine system, drug reinforcement, self-administration, psychostimulants, opiates, ethanol, cannabinoids, nicotine, dopamine transporter, ligand-gated ion channels, metabotropic receptors, addiction
MeSH terms
Ethanol, Central Nervous System Stimulants, Animals, Cannabinoids, Dopamine, Humans, Limbic System, Narcotics, Neural Pathways, Nicotine, Receptors, Dopamine, Reinforcement, Psychology, Mice, Knockout, Substance-Related Disorders, Dopamine Plasma Membrane Transport Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review